June 17, 2020 / 2:27 PM / 16 days ago

BRIEF-ALK-Abello Enters Into Co-Promotion Agreement With Otonomy

June 17 (Reuters) - ALK-Abello A/S:

* ALK ENTERS INTO CO-PROMOTION AGREEMENT WITH OTONOMY FOR OTIPRIO® (CIPROFLOXACIN OTIC SUSPENSION), THE FIRST AND ONLY SINGLE-DOSE TREATMENT FOR ACUTE OTITIS EXTERNA (SWIMMER’S EAR) Source text for Eikon: Further company coverage: (Gdansk Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below